ICA-17043

TERMINATED · PHASE3 · Sickle Cell Disease, Sickle Cell Anemia

Lack of efficacy demonstrated in study ICA-17043-10

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.